ERBB2 and breast carcinoma: For example, the American Society of Clinical Oncology/College of American Pathologists (ASCO-CAP) suggested guidelines for the effective use of the well-known breast cancer drug trastuzumab, using improved HER2 clinical test standards19, 20.